103
Participants
Start Date
August 29, 2025
Primary Completion Date
February 28, 2027
Study Completion Date
September 12, 2027
Biological sample for the measurement of suPAR levels.
Biological sample for the measurement of plasminogen activator receptor (suPAR) level at baseline and at 6 months follow up to assess the evolution of cardio-renal interaction in HF patients listed for heart transplant treated by GDMT including dapagliflozin.
NOT_YET_RECRUITING
CHU de Toulouse, Toulouse
NOT_YET_RECRUITING
CHU Bordeaux, Pessac
NOT_YET_RECRUITING
CHU Montpellier, Montpellier
NOT_YET_RECRUITING
CHU Rennes, Rennes
NOT_YET_RECRUITING
CHU Grenoble, La Tronche
NOT_YET_RECRUITING
Chu Nantes, Nantes
RECRUITING
Chru Nancy, Vandœuvre-lès-Nancy
NOT_YET_RECRUITING
CHU Strasbourg, Strasbourg
NOT_YET_RECRUITING
Hospice Civil de Lyon - Hôpital Louis PRADEL, Bron
NOT_YET_RECRUITING
Aphp Hegp, Paris
NOT_YET_RECRUITING
Chu Rouen, Rouen
Central Hospital, Nancy, France
OTHER